-
1
-
-
79953748230
-
Association between opioid prescribing patterns and opioid overdose-related deaths
-
Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. J Am Med Ass. 2011 ; 305: 1315-1321
-
(2011)
J Am Med Ass
, vol.305
, pp. 1315-1321
-
-
Asb, B.1
Valenstein, M.2
Bair, M.J.3
-
3
-
-
67650069173
-
Can abuse deterrent formulations make a difference? Expectation and speculation
-
Budman SH, Grimes Serrano JM, Butler SF. Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct J. 2009 ; 6: 8
-
(2009)
Harm Reduct J
, vol.6
, pp. 8
-
-
Budman, S.H.1
Grimes Serrano, J.M.2
Butler, S.F.3
-
4
-
-
80054118887
-
Abuse risks and routes of administration of different prescription opioid compounds and formulations
-
Butler SF, Black RA, Cassidy TA, et al. Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduct J. 2011 ; 8: 29
-
(2011)
Harm Reduct J
, vol.8
, pp. 29
-
-
Butler, S.F.1
Black, R.A.2
Cassidy, T.A.3
-
5
-
-
84883364148
-
Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment
-
Butler SF, Cassidy TA, Chilcoat H, et al. Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. J Pain. 2013 ; 14 (4). 351-358
-
(2013)
J Pain
, vol.14
, Issue.4
, pp. 351-358
-
-
Butler, S.F.1
Cassidy, T.A.2
Chilcoat, H.3
-
6
-
-
74049140024
-
Measuring attractiveness for abuse of prescription opioids
-
Butler SF, Fernandez KC, Chang A, et al. Measuring attractiveness for abuse of prescription opioids. Pain Med. 2010 ; 11: 67-80
-
(2010)
Pain Med
, vol.11
, pp. 67-80
-
-
Butler, S.F.1
Fernandez, K.C.2
Chang, A.3
-
7
-
-
36749032377
-
Prescription OxyContin abuse among patients entering addiction treatment
-
Carise D, Dugosh KL, McLellan AT, et al. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry. 2007 ; 164: 1750-1756
-
(2007)
Am J Psychiatry
, vol.164
, pp. 1750-1756
-
-
Carise, D.1
Dugosh, K.L.2
McLellan, A.T.3
-
8
-
-
77953673796
-
Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008
-
Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. Morb Mortal Wkly Rep. 2010 ; 59: 705-709
-
(2010)
Morb Mortal Wkly Rep
, vol.59
, pp. 705-709
-
-
-
9
-
-
25844526549
-
Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002-2004
-
Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002-2004. J Pain. 2005 ; 6: 662-672
-
(2005)
J Pain
, vol.6
, pp. 662-672
-
-
Cicero, T.J.1
Inciardi, J.A.2
Muñoz, A.3
-
11
-
-
84878694752
-
Design of a post-marketing study program to assess the effects of a reformulated extended-release oxycodone tablet on its abuse
-
Coplan PM, Chilcoat HD, Baumgartner T, et al. Design of a post-marketing study program to assess the effects of a reformulated extended-release oxycodone tablet on its abuse. Pharmacoepidemiol Drug Safety. 2012 ; 21: 446
-
(2012)
Pharmacoepidemiol Drug Safety
, vol.21
, pp. 446
-
-
Coplan, P.M.1
Chilcoat, H.D.2
Baumgartner, T.3
-
15
-
-
57449112519
-
Patterns of abuse among unintentional pharmaceutical overdose fatalities
-
Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. J Am Med Ass. 2008 ; 300: 2613-2620
-
(2008)
J Am Med Ass
, vol.300
, pp. 2613-2620
-
-
Hall, A.J.1
Logan, J.E.2
Toblin, R.L.3
-
16
-
-
79953768961
-
Development of tamper deterrent formulations: State of the pharmaceutical industry
-
Hamed E, Moe D. Development of tamper deterrent formulations: State of the pharmaceutical industry. Curr Drug Abuse Rev. 2010 ; 3: 139-146
-
(2010)
Curr Drug Abuse Rev
, vol.3
, pp. 139-146
-
-
Hamed, E.1
Moe, D.2
-
18
-
-
33846988964
-
Mechanisms of prescription drug diversion among drug-involved club- and street-based populations
-
Inciardi JA, Surratt HL, Kurtz SP, et al. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007 ; 8: 171-183
-
(2007)
Pain Med
, vol.8
, pp. 171-183
-
-
Inciardi, J.A.1
Surratt, H.L.2
Kurtz, S.P.3
-
19
-
-
73349124678
-
Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert panel report
-
Johanson C-E, Balster RL, Henningfield JE, et al. Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert panel report. Drug Alcohol Depend. 2009 ; 105: S65-71
-
(2009)
Drug Alcohol Depend
, vol.105
, pp. 65-71
-
-
Johanson, C.-E.1
Balster, R.L.2
Henningfield, J.E.3
-
20
-
-
79960373515
-
Tampering with prescription opioids: Nature and extent of the problem, health consequences, and solutions
-
Katz N, Dart RC, Bailey E, et al. Tampering with prescription opioids: Nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse. 2011 ; 37: 205-217
-
(2011)
Am J Drug Alcohol Abuse
, vol.37
, pp. 205-217
-
-
Katz, N.1
Dart, R.C.2
Bailey, E.3
-
21
-
-
49649085625
-
Internet-based survey of nonmedical prescription opioid use in the United States
-
Katz N, Fernandez K, Chang A, et al. Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain. 2008 ; 24: 528-535
-
(2008)
Clin J Pain
, vol.24
, pp. 528-535
-
-
Katz, N.1
Fernandez, K.2
Chang, A.3
-
22
-
-
34648813683
-
Challenges in the development of prescription opioid abuse-deterrent formulations
-
Katz NP, Adams EH, Chilcoat H, et al. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007 ; 23: 648-660
-
(2007)
Clin J Pain
, vol.23
, pp. 648-660
-
-
Katz, N.P.1
Adams, E.H.2
Chilcoat, H.3
-
23
-
-
33646068382
-
Research design strategies to evaluate the impact of formulations on abuse liability
-
McColl S, Sellers EM. Research design strategies to evaluate the impact of formulations on abuse liability. Drug Alcohol Depend. 2006 ; 83: S52-62
-
(2006)
Drug Alcohol Depend
, vol.83
, pp. 52-62
-
-
McColl, S.1
Sellers, E.M.2
-
24
-
-
78549264128
-
A flood of opioids, a rising tide of deaths
-
Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010 ; 363: 1981-1985
-
(2010)
N Engl J Med
, vol.363
, pp. 1981-1985
-
-
Okie, S.1
-
26
-
-
77956076519
-
Opioid formulations designed to resist/deter abuse
-
Raffa RB, Pergolizzi JV. Opioid formulations designed to resist/deter abuse. Drugs. 2010 ; 70: 1657-1675
-
(2010)
Drugs
, vol.70
, pp. 1657-1675
-
-
Raffa, R.B.1
Pergolizzi, J.V.2
-
27
-
-
77956707359
-
Abuse-deterrent and tamper-resistant opioid formulations: What is their role in addressing prescription opioid abuse?
-
Schneider JP, Matthews M, Jamison RN. Abuse-deterrent and tamper-resistant opioid formulations: What is their role in addressing prescription opioid abuse?. CNS Drugs. 2010 ; 24: 805-810
-
(2010)
CNS Drugs
, vol.24
, pp. 805-810
-
-
Schneider, J.P.1
Matthews, M.2
Jamison, R.N.3
-
28
-
-
33947222652
-
Relative abuse potential of opioid formulations in Canada: A structured field study
-
Sellers EM, Schuller R, Romach MK, et al. Relative abuse potential of opioid formulations in Canada: A structured field study. J Opioid Manag. 2006 ; 2: 219-227
-
(2006)
J Opioid Manag
, vol.2
, pp. 219-227
-
-
Sellers, E.M.1
Schuller, R.2
Romach, M.K.3
-
29
-
-
79953893278
-
Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing
-
Smith HS. Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing. Expert Opin Pharmacother. 2011 ; 12: 1111-1125
-
(2011)
Expert Opin Pharmacother
, vol.12
, pp. 1111-1125
-
-
Smith, H.S.1
-
30
-
-
0032381728
-
Route of drug use and its implications for drug effect, risk of dependence and health consequences
-
Strang J, Bearn J, Farrell M, et al. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev. 1998 ; 17: 197-211
-
(1998)
Drug Alcohol Rev
, vol.17
, pp. 197-211
-
-
Strang, J.1
Bearn, J.2
Farrell, M.3
-
31
-
-
84883394067
-
-
Substance Abuse and Mental Health Services Administration (accessed 6 June 2012)
-
Substance Abuse and Mental Health Services Administration (2005) Nonmedical oxycodone users: A comparison with heroin users. Available at: www.samhsa.gov/data/2k5/oxycodoneH/oxycodoneH.htm. (accessed 6 June 2012).
-
(2005)
Nonmedical Oxycodone Users: A Comparison with Heroin Users
-
-
-
32
-
-
79955787248
-
-
Substance Abuse and Mental Health Services Administration (accessed 6 June 2012)
-
Substance Abuse and Mental Health Services Administration (2007) Patterns and trends in nonmedical prescription pain reliever use: 2002 to 2005. Available at: www.oas.samhsa.gov/2k7/pain/pain.pdf. (accessed 6 June 2012).
-
(2007)
Patterns and Trends in Nonmedical Prescription Pain Reliever Use: 2002 to 2005
-
-
-
33
-
-
78649648381
-
-
United States Health and Human Services Food and Drug Administration (accessed 3 June 2013)
-
United States Health and Human Services Food and Drug Administration (2010) Guidance for industry: Assessment of abuse potential of drugs. Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM198650.pdf (accessed 3 June 2013).
-
(2010)
Guidance for Industry: Assessment of Abuse Potential of Drugs
-
-
-
34
-
-
84867881321
-
Assessment of a formulation designed to be crush-resistant in prescription opioid abusers
-
Vosburg SK, Jones JD, Manubay JM, et al. Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug Alcohol Depend. 2012 ; 126 (1-2). 206-15
-
(2012)
Drug Alcohol Depend
, vol.126
, Issue.12
, pp. 206-215
-
-
Vosburg, S.K.1
Jones, J.D.2
Manubay, J.M.3
-
35
-
-
73449108112
-
Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006
-
Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief. 2009 ;: 1-8
-
(2009)
NCHS Data Brief
, pp. 1-8
-
-
Warner, M.1
Chen, L.H.2
Makuc, D.M.3
-
36
-
-
84878726433
-
Oxycodone extended-release using gel-cap technology to resist alteration and abuse for the treatment of moderate-to-severe pain
-
Webster LR. Oxycodone extended-release using gel-cap technology to resist alteration and abuse for the treatment of moderate-to-severe pain. Pain Manage. 2011 ; 1: 417-425
-
(2011)
Pain Manage
, vol.1
, pp. 417-425
-
-
Webster, L.R.1
-
37
-
-
67449100590
-
Opioid formulations in development designed to curtail abuse: Who is the target?
-
Webster LR, Bath B, Medve RA. Opioid formulations in development designed to curtail abuse: Who is the target?. Expert Opin Investig Drugs. 2009 ; 18: 255-263
-
(2009)
Expert Opin Investig Drugs
, vol.18
, pp. 255-263
-
-
Webster, L.R.1
Bath, B.2
Medve, R.A.3
-
38
-
-
79960879545
-
Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users
-
Webster LR, Johnson FK, Stauffer J, et al. Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users. Drugs R D. 2011 ; 11: 259-275
-
(2011)
Drugs R D
, vol.11
, pp. 259-275
-
-
Webster, L.R.1
Johnson, F.K.2
Stauffer, J.3
-
39
-
-
77957922787
-
Route of administration for illicit prescription opioids: A comparison of rural and urban drug users
-
Young AM, Havens JR, Leukefeld CG. Route of administration for illicit prescription opioids: A comparison of rural and urban drug users. Harm Reduct J. 2010 ; 7: 24
-
(2010)
Harm Reduct J
, vol.7
, pp. 24
-
-
Young, A.M.1
Havens, J.R.2
Leukefeld, C.G.3
|